On February 27th, Johnson & Johnson (J&J), an American multinational corporation, announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine.
It’s only manufactured by the Janssen Pharmaceutical Companies of Johnson & Johnson to prevent COVID-19 transmission in people 18 years old and older.
This conclusion was made based only on positive scientific evidence, including the PHASE 3 ENSEMBLE study, which thoroughly demonstrated that the vaccine in question was 85% effective and far from average powerful in preventing deadly disease across all areas.
During the first 28 days after vaccination, it was examined on a daily basis and showed good COVID-19-related hospitalization and mortality rates.
Diagnosis of the clotting
The FDA said it discovered a possible link between Venous thromboembolism (VTE) and the J&J vaccine after reviewing two reports of deaths among women who were immunized with the company’s single-dose flu shot.
Venous thromboembolism (VTE) is a medical diagnosis for blood clots in veins, an underdiagnosed and serious yet preventable condition that might result in disability and death.
The most severe difficulty of DVT is when a clot goes through a fracture and travels via the circulation to the lungs. As a result, causing a blockage known as pulmonary embolism (PE).
Fortunately, if the clot is small and treated, most people will recover from PE. However, because of the strain on the lungs, there may be lung damage as well.
If the clot is substantial, it can obstruct blood flow to the lungs, resulting in bronchopulmonary segment blockage, which is a deadly condition that affects everyone.
Related:
The severity of this side effect
According to records, one-third to one-fifth of those who are diagnosed with DVT will develop long-term problems as a result of the damage the clot causes to the valves in the vein known as post-thrombotic syndrome (PTS).
In almost severe instances, people with PTS have symptoms such as edema, pain, discoloration, and scaling or ulcers in the afflicted region of the body. In some situations, the indicators can become serious enough to cause a person to lose their job.
Regardless of whether the vaccine is injected, VTE is most likely caused by an accident or lack of mobility in bedridden people. Cervical cancer and several chronic diseases are additional risk factors.
